NASDAQ:INM
InMed Pharmaceuticals Inc.
- Stock
Last Close
0.33
21/05 20:00
Market Cap
2.41M
Beta: 1.06
Volume Today
768.93K
Avg: 631.00K
PE Ratio
−0.16
PFCF: −0.24
Jun '13 | Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -46.74K - | -1.15M 2,365.21% | -3.46M 200.14% | -1.84M 46.87% | -3.44M 87.22% | -6.71M 95.01% | -10.10M 50.51% | -8.68M 14.02% | -10.20M 17.53% | -18.60M 82.30% | -7.95M 57.27% | |
depreciation and amortization | 40.30 - | 75.76K 187,863.85% | 67.41K 11.02% | 75.22K 11.58% | -92.78K 223.35% | 94.72K 202.09% | 161.97K 71.00% | 120.87K 25.38% | 511.79K 323.43% | 596.00K 16.45% | ||
deferred income tax | -2.25M - | 1.92 100.00% | 80.85K 4,202,564.79% | -242.39K 399.79% | 356.89K - | |||||||
stock based compensation | 666.83K - | 1.69M 152.98% | 695.20K 58.79% | 1.17M 67.59% | 2.43M 108.63% | 3.11M 27.96% | 917.11K 70.51% | 610.19K 33.47% | 777.77K 27.46% | 278.15K 64.24% | ||
change in working capital | 7.48K - | -156.08K 2,188.02% | 87.91K 156.32% | 688.73K 683.48% | -165.80K 124.07% | 431.40K 360.19% | 283.89K 34.19% | 351.30K 23.74% | -450.45K 228.22% | -2.73M 506.34% | -565.82K 79.28% | |
accounts receivables | 4.55K - | -24.08K 629.66% | 16.98K 170.52% | 40.20K 136.72% | -40.01K 199.53% | -219.15K 447.76% | ||||||
inventory | -431.94K - | -2.00M - | 565.56K 128.23% | |||||||||
accounts payables | 431.94K - | -928.41K - | ||||||||||
other working capital | 426.85K - | 307.97K 27.85% | 334.32K 8.55% | -490.65K 246.76% | -687.51K 40.12% | 16.17K 102.35% | ||||||
other non cash items | 0.00 - | -0.00 100.02% | 0.00 150% | 0.00 300% | 2.51M 538,140,289,584,332,672% | -71.39K 102.85% | 18.62K 126.08% | 374.23K 1,910.14% | 4.46M 1,091.27% | -803 100.02% | ||
net cash provided by operating activities | -39.26K - | -641.38K 1,533.59% | -1.61M 150.63% | -386.07K 75.98% | -2.37M 512.69% | -3.68M 55.50% | -6.68M 81.59% | -7.15M 7.07% | -9.79M 36.90% | -15.58M 59.17% | -7.28M 53.26% | |
investments in property plant and equipment | -2.03K - | -4.84K 138.09% | -885.00 81.73% | -19.52K 2,106.17% | -43.80K 124.35% | -27.03K 38.28% | -41.85K 54.81% | -1.73K 95.88% | -39.11K 2,167.13% | -161.80K 313.74% | ||
acquisitions net | 541.00 - | -208.89K - | -500K 139.36% | |||||||||
purchases of investments | -1.83M - | -2.06M 12.45% | -42.10K 97.96% | -425.00K - | -42.27K 90.05% | |||||||
sales maturities of investments | 3.70M - | 425K - | 42.27K 90.05% | |||||||||
other investing activites | 0.00 - | -17.03K 2,437,452,535,653,767% | -9.01 99.95% | -425.00K - | ||||||||
net cash used for investing activites | -2.03K - | -4.84K 138.09% | -885.00 81.73% | -19.52K 2,106.17% | -1.88M 9,514.42% | -2.11M 12.17% | 3.62M 271.90% | -1.73K 100.05% | -673.00K 38,914.43% | -661.80K 1.66% | ||
debt repayment | -71.30K - | -290.83K - | ||||||||||
common stock issued | 646.74K - | 1.83M 183.45% | 304.68K 83.38% | 8.27M 2,612.86% | 19.27M 133.20% | 207.57K 98.92% | -30.99K 114.93% | 12.47M 40,342.96% | 17.15M 37.47% | 12.00M 30.01% | ||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | -297.13 - | -92.75K 31,116.46% | -4.54K 95.11% | -764.62K 16,741.21% | 1.27K - | -1.62M 127,288.07% | -1.78M 10.32% | -1.32M 26.05% | ||||
net cash used provided by financing activities | 646.44K - | 1.74M 169.23% | 300.14K 82.75% | 7.50M 2,399.14% | 19.27M 156.97% | 207.57K 98.92% | -101.02K 148.67% | 10.85M 10,845.52% | 15.07M 38.84% | 10.68M 29.13% | ||
effect of forex changes on cash | 0.00 - | 0.81 80,559,313.34% | -0.00 100.00% | 2.31 15,851,507,948,900% | -469.47K 20,352,520.38% | 0.60 100.00% | -565.23K 93,786,365.07% | 494.96K 187.57% | -651 - | |||
net change in cash | -39.26K - | 3.03K 107.71% | 128.07K 4,131.64% | -86.82K 167.79% | 5.12M 5,992.66% | 13.25M 159.00% | -8.58M 164.73% | -3.63M 57.65% | 1.56M 142.87% | -1.19M 176.17% | 2.74M 330.61% | |
cash at beginning of period | 43.40K - | 4.08K 90.59% | 6.11K 49.63% | 128.74K 2,006.36% | 41.71K 67.61% | 5.10M 12,128.99% | 18.38M 260.45% | 9.43M 48.73% | 5.81M 38.41% | 7.36M 26.82% | 6.18M 16.11% | |
cash at end of period | 4.14K - | 7.11K 71.69% | 134.18K 1,786.92% | 41.92K 68.76% | 5.16M 12,202.18% | 18.35M 255.79% | 9.81M 46.56% | 5.79M 40.93% | 7.36M 27.10% | 6.18M 16.11% | 8.91M 44.29% | |
operating cash flow | -39.26K - | -641.38K 1,533.59% | -1.61M 150.63% | -386.07K 75.98% | -2.37M 512.69% | -3.68M 55.50% | -6.68M 81.59% | -7.15M 7.07% | -9.79M 36.90% | -15.58M 59.17% | -7.28M 53.26% | |
capital expenditure | -2.03K - | -4.84K 138.09% | -885.00 81.73% | -19.52K 2,106.17% | -43.80K 124.35% | -27.03K 38.28% | -41.85K 54.81% | -1.73K 95.88% | -39.11K 2,167.13% | -161.80K 313.74% | ||
free cash flow | -39.26K - | -643.42K 1,538.77% | -1.61M 150.59% | -386.96K 76.00% | -2.38M 516.34% | -3.72M 56.06% | -6.71M 80.18% | -7.19M 7.26% | -9.79M 36.13% | -15.62M 59.54% | -7.45M 52.35% |
All numbers in USD (except ratios and percentages)